DNAPrint Pharmaceuticals Completes the Development of a Third Assay for PT-401 (RedNova)
DNAPrint Genomics, Inc. (OTCBB: DNAG) today an

MGI Drug Approval Falters (Motley Fool via Yahoo! Finance)
The FDA gives the thumbs-down to Saforis.

MGI Drug Approval Falters (The Motley Fool via Yahoo! News)
The reality of an uninformed public (who don't always adequately weigh drug risks and benefits) necessitates government oversight to "protect" patients. This task falls upon the U.S. Food and Drug Administration (FDA), and unfortunately, any perceived failing of the agency to sufficiently inform the public of a drug's risk brings calls for tighter drug approval standards. Some argue that the